| Literature DB >> 33299857 |
Yuan Yue1,2, Suiqing Huang1, Zixuan Wu3, Keke Wang1, Huayang Li1, Jian Hou1, Xiaolin Huang1, Li Luo1, Quan Liu1, Zhongkai Wu1,2.
Abstract
Exosomes transmit certain amounts of molecules to specific recipient cells for intercellular communication. Among these molecules, messenger RNAs (mRNAs) may be delivered and translated into proteins in the recipient cells, and these mRNAs are thought to be critical mediators of exosomal functions. There are three subtypes of M2 macrophages (M2Ф), M2aФ, M2bФ, and M2cФ, which have different specific functional programs. The aim of the present study was to screen the mRNA profiles in the exosomes of these macrophage subtypes and to analyze the transcriptomic profile features associated with their specific functions. The mRNA contents of the exosomes isolated from the culture supernatants of the M2Ф subtypes were analyzed and compared using the Illumina HiSeq platform. The results indicated that the exosomes contained particular mRNAs from their source cells and were messengers of cellular functions. Bioinformatics analysis suggested that the exosomal mRNAs from M2bФs are enriched in the Toll-like receptor (TLR), tumor necrosis factor (TNF), NOD-like receptor (NLR), and NF-kappa B (NF-κB) signaling pathways. The mRNA profile of exosomes from M2bФ was distinctly different from that of exosomes from M2aФ and M2cФ and was consistent with the M2bФ cytological characteristic of maintaining a high level of proinflammatory cytokine and regulatory factor production. Therefore, the mRNA profiles revealed several characteristics of the exosomes from diverse forms of M2Ф. Further functional investigations based on these results may advance the understanding of the physiological roles of exosome-transferred mRNAs in MФ functions.Entities:
Mesh:
Substances:
Year: 2020 PMID: 33299857 PMCID: PMC7704128 DOI: 10.1155/2020/1585306
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Primer sequences used for RT-PCR.
| Gene (rat) | Forward | Reverse |
|---|---|---|
| GAPDH | GGTCATCCATGACAACTT | GGGGCCATCCACAGTCTT |
| CCL17 | AGTGCTGCCTGGACTACTTC | CTGGACAGTCTCAAACACGATGG |
| CCL1 | GAGCCTGCAGTTTCACTCA | GATCTGTGAGCCTGCATCAGT |
| CXCL13 | ACATGCCTAGACTGAGAGCT | AAGGCAGATGGCCAGTAGAAG |
CCL: C-C motif chemokine ligand; CXCL: C-X-C motif chemokine ligand.
Figure 1Identification of M2Фs and exosomes. (a) Procedure for the identification of BMDMs positive for CD45 and CD68 by flow cytometry. (b) Gene expression profiles of the different M2Ф phenotypes measured by reverse transcription-quantitative PCR. M2aФs, M2bФs, and M2cФs expressed high levels of CCL17, CCL1, and CXCL13, respectively. Data are presented as fold changes relative to the expression levels in untreated BMDMs and are the mean of three independent experiments. ∗P < 0.05. (c) Representative transmission electron microscopy image of exosomes (scale bar, 200 nm). (d) The size and concentration of exosomes measured by qNano analysis. (e) Western blot analysis of exosome marker proteins and negative protein. BMDM: bone marrow-derived macrophage; CCL: C-C motif chemokine ligand; CXCL: C-X-C motif chemokine ligand.
Figure 2Top 30 most abundant mRNAs in exosomes from different M2Фs and the pathway networks. The top 30 mRNAs in the exosomes are presented in the Venn diagram. The GO pathway networks of the mRNAs were categorized using CluePedia. The threshold for the network analysis was set to P < 0.05 and FDR < 0.05. GO: Gene Ontology; FDR: false discovery rate.
Unique mRNAs in exosomes of different group.
| Symbol | Description |
|---|---|
| Unique mRNAs in Exo-M2a | |
|
| Alpha-kinase 2 |
|
| CD55 molecule, decay-accelerating factor for complement |
|
| Connector enhancer of kinase suppressor of Ras 1 |
|
| Dystrophin |
|
| Docking protein 5 |
|
| Endothelin 1 |
|
| Family with sequence similarity 26, member D |
|
| hes-related family bHLH transcription factor with YRPW motif 1 |
|
| Deoxyribonuclease gamma-like |
|
| Monoamine oxidase B |
|
| T-cell immunoglobulin and mucin domain containing 2 |
|
| X-prolyl aminopeptidase 2 |
| Unique mRNAs in Exo-M2b | |
|
| Cysteine dioxygenase type 1 |
|
| Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme |
|
| G protein-coupled receptor 84 |
|
| Interleukin 2 receptor subunit alpha |
|
| Small proline-rich protein 2I-like |
|
| Killer cell lectin-like receptor 4 |
|
| Uncharacterized LOC103692615 |
|
| Similar to cytoplasmic beta-actin |
|
| Notch-regulated ankyrin repeat protein |
|
| Podocan-like 1 |
|
| Prostaglandin-endoperoxide synthase 2 |
|
| Serine (or cysteine) peptidase inhibitor, clade B, member 6b |
|
| Small nucleolar RNA host gene 4 (nonprotein coding) |
| Unique mRNA in Exo-M2c | |
|
| Solute carrier family 35, member G1 |
Figure 3Volcano plot comparing the levels of mRNA abundance between groups. Red and green dots represent upregulated and downregulated mRNAs (>2.0-fold change and P < 0.05), respectively.
Top 30 different abundant mRNAs in exosomes between groups.
| Exo-M2b vs. Exo-M2a | Exo-M2a vs. Exo-M2c | Exo-M2b vs. Exo-M2c | |||
|---|---|---|---|---|---|
| Gene | log2(FC) | Gene | log2(FC) | Gene | log2(FC) |
| Upregulation | |||||
|
| 9.67 |
| 8.48 |
| 8.76 |
|
| 7.81 |
| 8.46 |
| 8.62 |
|
| 7.25 |
| 8.43 |
| 8.46 |
|
| 7.23 |
| 8.22 |
| 8 |
|
| 7.22 |
| 7.97 |
| 7.51 |
|
| 7.15 |
| 7.91 |
| 7.29 |
|
| 7.08 |
| 7.3 |
| 7.08 |
|
| 6.95 |
| 7.1 |
| 7.07 |
|
| 6.89 |
| 6.98 |
| 7.01 |
|
| 6.85 |
| 6.97 |
| 6.96 |
|
| 6.81 |
| 6.9 |
| 6.95 |
|
| 6.75 |
| 6.83 |
| 6.93 |
|
| 6.74 |
| 6.77 |
| 6.84 |
|
| 6.65 |
| 6.54 |
| 6.82 |
| Downregulation |
| 6.13 |
| 6.82 | |
|
| -9.53 |
| 5.57 |
| 6.76 |
|
| -9.05 |
| 5.26 |
| 6.73 |
|
| -8.75 |
| 5.19 |
| 6.69 |
|
| -7.91 |
| 5.17 |
| 6.68 |
|
| -7.83 |
| 4.63 |
| 6.6 |
|
| -7.67 |
| 4.61 |
| 6.58 |
|
| -7.67 | Downregulation |
| 6.55 | |
|
| -7.52 |
| -7.57 |
| 6.51 |
|
| -7.51 |
| -6.68 |
| 6.49 |
|
| -7.45 |
| -6.42 | Downregulation | |
|
| -7.29 |
| -6.18 |
| -8.26 |
|
| -7.14 |
| -5.44 |
| -7.48 |
|
| -6.96 |
| -5.13 |
| -7.47 |
|
| -6.86 |
| -4.85 |
| -7.16 |
|
| -6.74 |
| -4.69 |
| -6.50 |
log2(FC): log2(fold change); positive numbers: upregulation; negative numbers: downregulation.
Figure 4KEGG pathway analysis of the differentially abundant mRNAs between groups. The size of the circles indicates the number of genes involved in the pathway, and the color of the circles represents the P value. The threshold for the analysis was set to P < 0.05 and FDR < 0.05. KEGG: Kyoto of Encyclopedia of Genes and Genomes; FDR: false discovery rate.
Figure 5GO analysis of the differentially abundant mRNAs between groups. Bar graphs indicate the number of genes that belong to the category. The threshold for the analysis was set to P < 0.05 and FDR < 0.05. GO: Gene Ontology; FDR: false discovery rate.
Figure 6Cluster analysis of the inflammation-associated mRNA profile of the exosomes from the three M2Ф subtypes. The ratios presented in this figure were determined by comparison to the mRNA expression of the exosomes from BMDMs. Each column represents the indicated sample; each row indicates a significant fold change in mRNA. Upregulated and downregulated genes are indicated in red and blue, respectively. BMDM: bone marrow-derived macrophages.